As of 2024-12-13, the Fair Value of EyePoint Pharmaceuticals Inc (EYPT) is -7.60 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 7.94 USD, the upside of EyePoint Pharmaceuticals Inc is -195.77%.
Note: valuation result may not be accurate due to the company's negative EPS.
Peter Lynch's formula is:
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.
| Historical Earnings | ||||||
| 2019-12-31 | 2020-12-31 | 2021-12-31 | 2022-12-31 | 2023-12-31 | 5Y Avg | |
| Net income | -56.79 | -45.39 | -58.42 | -102.25 | -70.79 | -66.73 |
| YoY growth | -6.81% | 20.07% | -28.71% | -75.03% | 30.76% | -11.94% |
| Market Cap (mil) | 540.71 |
| P/E | |
| Forward P/E |
| EPS | -1.52 |
| Avg earnings growth rate | -11.94% |
| TTM earnings | -103.57 |